Australia markets closed

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
166.58+0.92 (+0.56%)
At close: 04:00PM EDT
163.30 -3.28 (-1.97%)
After hours: 04:03PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
638,764
638,764
801,536
670,534
366,260
Cost of revenue
353,922
353,922
345,830
279,280
156,634
Gross profit
284,842
284,842
455,706
391,254
209,626
Operating expenses
Research development
42,722
42,722
43,936
34,274
20,182
Selling general and administrative
218,113
218,113
215,829
183,866
119,621
Total operating expenses
260,835
260,835
259,765
218,140
139,803
Operating income or loss
24,007
24,007
195,941
173,114
69,823
Interest expense
1,951
1,951
1,162
11,278
10,768
Total other income/expenses net
50,151
50,151
26,176
-6,857
1,527
Income before tax
64,132
64,132
219,140
153,543
59,217
Income tax expense
22,555
22,555
33,181
25,252
-709
Income from continuing operations
41,577
41,577
185,959
128,291
59,926
Net income
41,577
41,577
185,959
128,291
59,926
Net income available to common shareholders
41,577
41,577
185,959
128,291
59,926
Basic EPS
2.07
0.75
3.35
2.33
1.14
Diluted EPS
2.03
0.74
3.24
2.24
1.11
Basic average shares
55,652
55,720
55,460
55,015
52,554
Diluted average shares
56,956
56,377
57,455
57,264
53,892